Merck To Buy Bone Marrow Cancer Firm In $1.35B Deal
Pharmaceutical giant Merck & Co. on Monday announced plans to acquire clinical stage biopharmaceutical company Imago BioSciences in a $1.35 billion deal guided by respective legal advisers Gibson Dunn & Crutcher...To view the full article, register now.
Already a subscriber? Click here to view full article